MRI accuracy in residual disease evaluation in breast cancer patients treated with neoadjuvant chemotherapy.

[1]  L. Brunereau,et al.  Contrast enhanced magnetic resonance imaging underestimates residual disease following neoadjuvant docetaxel based chemotherapy for breast cancer. , 2004, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[2]  R. Warren,et al.  Can breast MRI help in the management of women with breast cancer treated by neoadjuvant chemotherapy? , 2004, British Journal of Cancer.

[3]  H. Junkermann,et al.  Accuracy of tumor size measurement in breast cancer using MRI is influenced by histological regression induced by neoadjuvant chemotherapy , 2003, European Radiology.

[4]  Min-Ying Su,et al.  Monitoring the Size and Response of Locally Advanced Breast Cancers to Neoadjuvant Chemotherapy (Weekly Paclitaxel and Epirubicin) with Serial Enhanced MRI , 2003, Breast Cancer Research and Treatment.

[5]  Ying Lu,et al.  Accuracy of MR imaging for revealing residual breast cancer in patients who have undergone neoadjuvant chemotherapy. , 2002, AJR. American journal of roentgenology.

[6]  A. Del Maschio,et al.  Magnetic Resonance in breast imaging. , 2002, La Radiologia medica.

[7]  C. Balu-Maestro,et al.  Imaging in Evaluation of Response to Neoadjuvant Breast Cancer Treatment Benefits of MRI , 2002, Breast Cancer Research and Treatment.

[8]  A. Rieber,et al.  Breast MRI for monitoring response of primary breast cancer to neo-adjuvant chemotherapy , 2002, European Radiology.

[9]  G J Metzger,et al.  MRI vs. histologic measurement of breast cancer following chemotherapy: Comparison with x‐ray mammography and palpation , 2001, Journal of magnetic resonance imaging : JMRI.

[10]  M D Schnall,et al.  An overview of interpretation strategies for breast MR imaging. , 2001, Magnetic resonance imaging clinics of North America.

[11]  T. Ishibashi,et al.  Correlation of three-dimensional magnetic resonance imaging with precise histopathological map concerning carcinoma extension in the breast , 2000, Breast Cancer Research and Treatment.

[12]  S. Singletary,et al.  Neoadjuvant chemotherapy in women with invasive breast carcinoma: conceptual basis and fundamental surgical issues. , 2000, Journal of the American College of Surgeons.

[13]  R Musumeci,et al.  Locally Advanced Breast Cancer Treated with Primary Chemotherapy: Comparison between Magnetic Resonance Imaging and Pathologic Evaluation of Residual Disease , 1999, Tumori.

[14]  C. Conrad,et al.  Pre-operative MR-mammography in breast cancer patients. , 1999, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[15]  L. Blumenson,et al.  Angiogenesis and dynamic MR imaging gadolinium enhancement of malignant and benign breast lesions , 1997, Breast Cancer Research and Treatment.

[16]  H Mumtaz,et al.  Staging of symptomatic primary breast cancer with MR imaging. , 1997, AJR. American journal of roentgenology.

[17]  H Zeitler,et al.  MRI of breast cancer: influence of chemotherapy on sensitivity. , 1997, The British journal of radiology.

[18]  S E Harms,et al.  Evaluation of neoadjuvant chemotherapeutic response of locally advanced breast cancer by magnetic resonance imaging , 1996, Cancer.

[19]  J O Barentsz,et al.  Breast tumors: comparative accuracy of MR imaging relative to mammography and US for demonstrating extent. , 1995, Radiology.

[20]  G Brix,et al.  MR mammography with pharmacokinetic mapping for monitoring of breast cancer treatment during neoadjuvant therapy. , 1994, Magnetic resonance imaging clinics of North America.

[21]  G. Calais,et al.  Conservative treatment feasibility with induction chemotherapy, surgery, and radiotherapy for patients with breast carcinoma larger than 3 cm , 1994, Cancer.

[22]  R. Gilles,et al.  Locally advanced breast cancer: contrast-enhanced subtraction MR imaging of response to preoperative chemotherapy. , 1994, Radiology.

[23]  G. Schwartz,et al.  Induction chemotherapy followed by breast conservation for locally advanced carcinoma of the breast , 1994, Cancer.

[24]  G. Bonadonna.  Evolving concepts in the systemic adjuvant treatment of breast cancer. , 1992, Cancer research.

[25]  W. Kraybill,et al.  Multimodal therapy in locally advanced breast carcinoma. , 1990, American journal of surgery.

[26]  G. Hortobagyi,et al.  Management of stage III primary breast cancer with primary chemotherapy, surgery, and radiation therapy , 1988, Cancer.

[27]  A. Leitch,et al.  Multimodality treatment of locally advanced breast carcinoma. , 1988, Archives of surgery.

[28]  G. Hortobagyi,et al.  Pathological assessment of response to induction chemotherapy in breast cancer. , 1986, Cancer research.

[29]  D. Altman,et al.  STATISTICAL METHODS FOR ASSESSING AGREEMENT BETWEEN TWO METHODS OF CLINICAL MEASUREMENT , 1986, The Lancet.

[30]  J. Aisner,et al.  Mastectomy as an adjuvant to chemotherapy for locally advanced or metastatic breast cancer. , 1982, Archives of surgery.

[31]  G. Cocconi,et al.  Problems in evaluating response of primary breast cancer to systemic therapy , 2005, Breast Cancer Research and Treatment.

[32]  Melinda J. Staiger,et al.  Breast cancer measurements with magnetic resonance imaging, ultrasonography, and mammography , 2005, Breast Cancer Research and Treatment.

[33]  L. Esserman,et al.  Utility of magnetic resonance imaging in the management of breast cancer: evidence for improved preoperative staging. , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[34]  P. L. Davis,et al.  Sensitivity of enhanced MRI for the detection of breast cancer: new, multicentric, residual, and recurrent , 1997, European Radiology.

[35]  Heywang-Köbrunner Sh,et al.  Contrast-enhanced magnetic resonance imaging of the breast. , 1994, Investigative radiology.

[36]  L. Olivetti,et al.  Diagnostica per immagini , 1987 .